Migrastatics-Anti-metastatic and Anti-invasion Drugs: Promises and Challenges

Area of Science:

• Oncology
• Cancer Research
• Drug Discovery

Background:

• Solid cancer invasion and metastasis cause over 90% of cancer mortality.
• Current anticancer therapies lack specific anti-invasion and antimetastatic drugs.
• A new class of drugs, migrastatics, is proposed to target cancer cell invasion and metastasis.

Purpose of the Study:

• To introduce the concept and term 'migrastatics' for drugs targeting cancer cell invasion and metastasis.
• To differentiate migrastatics from conventional cytostatic drugs.
• To identify potential therapeutic targets and candidate drugs for migrastatics.

Main Methods:

• Literature review and conceptualization of a new drug class.
• Definition of therapeutic targets, including actin polymerization and contractility.
• Identification and preliminary assessment of candidate migrastatic drugs.

Main Results:

• The term 'migrastatics' is defined for drugs inhibiting cancer cell invasion and metastasis.
• Actin polymerization and contractility are identified as key mechanisms for migrastatic drug targeting.
• Several candidate migrastatic agents are reviewed for their potential efficacy.

Conclusions:

• Migrastatics represent a novel therapeutic strategy distinct from cytostatic agents.
• Targeting cancer cell migration mechanisms offers a new avenue for treating solid cancers.
• Further research and critical assessment of migrastatic agents are necessary to establish their clinical utility.